Mark Fereshteh
- Molecular Biology top 10%
- Oncology top 10%
- Hematology top 5%
- Genetics top 10%
- Genetics top 5%
- Co-authors
- Tannishtha ReyaJuyong Brian KimPhilip A. BeachyHyog Young KwonJordan BlumAnnelie AbrahamssonCatriona JamiesonTodd VanArsdale
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Immunotherapy and Immune Responses (5 papers)CAR-T cell therapy research (4 papers)
- Cited by
- HematologyGeneticsOncology
- Journals
- NatureProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Mark Fereshteh
17 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 1.0k
- Oncology 445
- Hematology 247
- Genetics 216
- Genetics 178
Countries citing papers authored by Mark Fereshteh
This map shows the geographic impact of Mark Fereshteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fereshteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fereshteh more than expected).
Fields of papers citing papers by Mark Fereshteh
This network shows the impact of papers produced by Mark Fereshteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fereshteh. The network helps show where Mark Fereshteh may publish in the future.
Co-authorship network of co-authors of Mark Fereshteh
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Fereshteh. A scholar is included among the top collaborators of Mark Fereshteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Fereshteh. Mark Fereshteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 33 | |
| 11 | 42 | |
| 12 | 47 | |
| 13 | 421 | |
| 14 | Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemiabreakdown → | 676 |
| 15 | 82 | |
| 16 | 45 | |
| 17 | 55 | |
| 18 | 18 |
About Mark Fereshteh
Mark Fereshteh is a scholar working on Oncology, Immunology and Pharmacy, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (247 citations), Genetics (178 citations) and Oncology (445 citations). Mark Fereshteh has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Tannishtha Reya, Juyong Brian Kim, Philip A. Beachy, Hyog Young Kwon, Jordan Blum, Annelie Abrahamsson, Catriona Jamieson, Todd VanArsdale, Alan Chen and David A. Rizzieri. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.